Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimal Residual Disease”

438 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 438 results

Early research (Phase 1)Study completedNCT01757639
What this trial is testing

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+3 more
National Cancer Institute (NCI) 42
Early research (Phase 1)UnknownNCT04604691
What this trial is testing

Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)

Who this might be right for
Pediatric ALL, B CellMinimal Residual Disease
Seoul National University Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04689815
What this trial is testing

Oral Arsenic Trioxide for NPM1-mutated AML

Who this might be right for
NPMc+ AML
The University of Hong Kong 50
Testing effectiveness (Phase 2)Study completedNCT02458014
What this trial is testing

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Who this might be right for
Adult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more
M.D. Anderson Cancer Center 36
Not applicableEnrolling By InvitationNCT06102889
What this trial is testing

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES

Who this might be right for
Pancreatic Adenocarcinoma
Karolinska University Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05628623
What this trial is testing

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment

Who this might be right for
Leukemia, Myeloid, Acute
Eastern Cooperative Oncology Group 184
Large-scale testing (Phase 3)UnknownNCT03624530
What this trial is testing

Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaTyrosine Kinase InhibitorMinimal Residual Disease+1 more
Nanfang Hospital, Southern Medical University 82
Testing effectiveness (Phase 2)Looking for participantsNCT05904106
What this trial is testing

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 146
Testing effectiveness (Phase 2)UnknownNCT03697655
What this trial is testing

Pre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Polish Myeloma Consortium 274
Not applicableUnknownNCT05969938
What this trial is testing

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Who this might be right for
Rectal AdenocarcinomaCirculating Tumor DNAMinimal Residual Disease+1 more
WeiWei Xiao 50
Not applicableActive Not RecruitingNCT06744075
What this trial is testing

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

Who this might be right for
B-cell LymphomaHodgkin Lymphoma
Centre Henri Becquerel 108
Not applicableUnknownNCT05167604
What this trial is testing

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNext-Generation SequencingChemotherapy, Adjuvant+2 more
Tang-Du Hospital 150
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Not applicableLooking for participantsNCT05198154
What this trial is testing

CtDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Advanced Lung Non-Small Cell Carcinoma
Fang Wu 100
Not applicableUnknownNCT05371873
What this trial is testing

Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 250
Testing effectiveness (Phase 2)Ended earlyNCT03951961
What this trial is testing

Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia, Adult
University of Jena 1
Not applicableLooking for participantsNCT06211166
What this trial is testing

Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

Who this might be right for
Acute LeukemiaMDSMDS/MPN+1 more
Peking University People's Hospital 300
Not applicableLooking for participantsNCT01499394
What this trial is testing

Caris Biorepository Research Protocol

Who this might be right for
CancerEarly Detection of CancerMinimal Residual Disease
Caris Science, Inc. 100,000
Early research (Phase 1)Study completedNCT03919526
What this trial is testing

Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL

Who this might be right for
MRD-positiveAcute Lymphoblastic Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 19
Testing effectiveness (Phase 2)Study completedNCT00267085
What this trial is testing

Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease

Who this might be right for
Chronic Myeloid LeukemiaMinimal Residual Disease
M.D. Anderson Cancer Center 11
Load More Results